AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
1.190
-0.010 (-0.83%)
At close: May 12, 2025, 4:00 PM
1.190
0.00 (0.00%)
After-hours: May 12, 2025, 4:00 PM EDT
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $35.82 million as of May 12, 2025. Its market cap has decreased by -49.87% in one year.
Market Cap
35.82M
Enterprise Value
-47.80M
1-Year Change
-49.87%
Ranking
Category
Stock Price
$1.19
Market Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $35.82M, a decrease of -87.26%. That is a compound annual growth rate of -48.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 36.12M | -12.40% |
| Dec 31, 2024 | 41.23M | -93.23% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |